A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine
|
|||||
|
|
 Comments are closed  Finance, New products  biomedical, biotechnology, entrepreneurs, Europe, grant, licensing, life sciences, pharmaceuticals, preclinical 
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial One comment - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Europe, FDA, life sciences, pharmaceuticals, preclinical 
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe Comments are closed New products biomedical, biotechnology, cancer, clinical trials, genomics, life sciences, pharmaceuticals 
A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested. . . . → Read More: Trial Shows Two Drugs Can Treat Ebola Virus Comments are closed New products, Regulations Africa, biomedical, biotechnology, clinical trials, life sciences, NIH, pharmaceuticals 
Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces. . . . → Read More: Engineered Bacteria Hydrogels Designed for Gut Repair 3 comments - (Comments are closed) New products biomedical, biotechnology, engineering, genomics, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers. . . . → Read More: MD Anderson, Drug Maker Partner on Lung, GI Cancers Comments are closed Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, life sciences, pharmaceuticals, preclinical, university 
A company developing a food preservation technology from university materials science labs is raising $4 million in its seed funding round. . . . → Read More: Food Technology Company Gains $4M in Seed Funds Comments are closed Finance agriculture, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, materials science, physical sciences, university, venture capital 
The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, pharmaceuticals, preclinical 
A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities. . . . → Read More: Company Forms to Treat Vaginal Microbial Disorders Comments are closed Intellectual property, New products biomedical, biotechnology, clinical trials, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
A vaccine made with nanoscale peptide particles can prevent the occurrence of melanoma in lab mice, and treat the condition when combined with other drugs. . . . → Read More: Nanotech Vaccine Aids Melanoma Immunotherapy 2 comments - (Comments are closed) New products biomedical, biotechnology, cancer, Europe, Israel, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||